Your Journey to Weight Loss Starts Here During your initial consultation, a healthcare provider will review your medical history, family history, and current medications to create a personalized treatment plan
We dont know what the exact risk is, Henderson says
Its molecular structure: Approximately 39 amino acids Synthetic, manufactured via Solid-Phase Peptide Synthesis Fatty acid-conjugated for extended biological half-life Rationally designed for balanced activation across GLP-1, GIP, and glucagon receptors The Phase 2 clinical trial data, published in the New England Journal of Medicine in 2023, reported substantial metabolic effects that exceeded what previous-generation single and dual agonists had produced
Yet, with the advent of these new agents comes the clinical dilemma of how to use them in a safe, cost-effective manner
Because GLP-1 agonists slow down the digestive tract, they can potentially worsen constipation
Do we teach them that leaving a harmful situation is sometimes healthier than surviving in it